# A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius

> **NCT00548496** · PHASE2 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 86 (actual)

## Conditions studied

- Fracture Healing

## Interventions

- **DRUG:** SB-751689
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00548496
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09-20
- **Primary completion:** 2008-11-26
- **Final completion:** 2008-11-26
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Lack of efficacy
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548496, "A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00548496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*